Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4361549A · kind A · utility
54Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 1979 |
| Grant date | Nov 30, 1982 |
| Priority date | — |
| Expiry date | Apr 26, 1999 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human T cells and cutaneous T lymphoma cells. The hybrid is formed by fusing splenocytes from immunized CAF.sub.1 mice with P3X63Ag8Ul myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.